SCHEMBL577982

SCHEMBL577982

CC(C)c1csc(-c2n[c]nc3cccc(Cl)c23)n1

nearest known ligand 0.33

Predicted protein targets (top 7)

geneUniProtsupporting neighboursconfidence
CCR4 P51679 1/20 0.33
TYK2 P29597 1/20 0.33
PARP1 P09874 1/20 0.31
DHODH Q02127 1/20 0.31
SHMT1 P34896 1/20 0.30
SHMT2 P34897 1/20 0.30
PANK3 Q9H999 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL577977 0.86 TYK2 (0.42) CCR4TYK2PARP1
SCHEMBL577505 0.84 ALDH1A1 (0.36) CCR4TYK2SHMT2
SCHEMBL577981 0.83 TYK2 (0.35) CCR4TYK2SHMT1SHMT2
SCHEMBL577533 0.79 APLNR (0.33)
SCHEMBL577976 0.78 TYK2 (0.39) CCR4TYK2
SCHEMBL577703 0.76 APLNR (0.32)
SCHEMBL577504 0.76 TYK2 (0.34) CCR4TYK2
SCHEMBL15640643 0.75 TYK2 (0.41) CCR4TYK2SHMT1SHMT2PANK3
SCHEMBL577608 0.75 SLC10A2 (0.35)
SCHEMBL577639 0.74 APLNR (0.33) TYK2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2461811-A1 MACROCYCLIC SERINE PROTEASE INHIBITORS USEFUL AGAINST VIRAL INFECTIONS, PARTICULARLY HCV IDENIX Pharmaceuticals, Inc. (US) 2012-06-13 EP claimed
EP-2417134-A1 MACROCYCLIC SERINE PROTEASE INHIBITORS IDENIX Pharmaceuticals, Inc. (US) 2012-02-15 EP claimed
WO-2011017389-A1 MACROCYCLIC SERINE PROTEASE INHIBITORS USEFUL AGAINST VIRAL INFECTIONS, PARTICULARLY HCV IDENIX PHARMACEUTICALS, INC. (US) 2011-02-10 WO claimed
WO-2010118078-A1 MACROCYCLIC SERINE PROTEASE INHIBITORS IDENIX PHARMACEUTICALS, INC. (US) 2010-10-14 WO claimed